You have 9 free searches left this month | for more free features.

MGD

Showing 1 - 25 of 169

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Meibomian Gland Dysfunction, Dry Eye Disease Trial in Miami, Marlborough, Buenos Aires (Nordlys SWT IPL, Meibomian Gland

Recruiting
  • Meibomian Gland Dysfunction
  • Dry Eye Disease
  • Nordlys SWT IPL
  • Meibomian Gland Expression (MGX)
  • Miami, Florida
  • +2 more
Sep 26, 2023

Meibomian Gland Dysfunction Trial in Sydney (AZR-MD-001 ointment/semi-solid drug)

Completed
  • Meibomian Gland Dysfunction
  • AZR-MD-001 ointment/semi-solid drug
  • Sydney, New South Wales, Australia
    Fiona Stapleton
Apr 25, 2022

Human Immunodeficiency Virus I Infection, Immunodeficiency Virus Type 1, Human, Human Immunodeficiency Virus Type 1 Trial in New

Not yet recruiting
  • Human Immunodeficiency Virus I Infection
  • +2 more
  • MGD020
  • MGD014
  • (no location specified)
Jun 27, 2022

Meibomian Gland Dysfunction of Unspecified Eye, Unspecified Eyelid Trial in Tianjin (Routine preoperative and postoperative

Completed
  • Meibomian Gland Dysfunction of Unspecified Eye, Unspecified Eyelid
  • Routine preoperative and postoperative anti-infection therapy
  • +2 more
  • Tianjin, Tianjin, China
    Tianjin medical university eye hosipital
Mar 4, 2023

Dry Eye, Meibomian Gland Dysfunction Trial in Guangzhou (Warm compresses, 3% Diquafosol Sodium Eye Drops)

Not yet recruiting
  • Dry Eye
  • Meibomian Gland Dysfunction
  • Warm compresses
  • 3% Diquafosol Sodium Eye Drops
  • Guangzhou, Guangdong, China
    Zhongshan Ophthalmic Center, Sun Yat-Sen University
Aug 5, 2022

HIV-1-infection Trial in Chapel Hill (MGD014)

Completed
  • HIV-1-infection
  • MGD014
  • Chapel Hill, North Carolina
    University of North Carolina Chapel Hill
Aug 31, 2022

Dry Eye Trial in Toronto, Waterloo (I-DROP MGD, Thealoz Duo)

Completed
  • Dry Eye
  • I-DROP MGD
  • Thealoz Duo
  • Toronto, Ontario, Canada
  • +1 more
Mar 28, 2022

Advanced Hepatocellular Carcinoma (HCC) Trial in Hong Kong (MGD013 monotherapy, MGD013 in combination with Brivanib Alaninate)

Terminated
  • Advanced Hepatocellular Carcinoma (HCC)
  • MGD013 monotherapy
  • MGD013 in combination with Brivanib Alaninate
  • Hong Kong, Hong Kong, China
    Prince of Wales Hospital
Jun 8, 2022

Dry Eye Disease, Meibomian Gland Dysfunction Trial in New York, Harrisburg (IPL_RF_MGX)

Recruiting
  • Dry Eye Disease
  • Meibomian Gland Dysfunction
  • IPL_RF_MGX
  • New York, New York
  • +1 more
Aug 1, 2022

Quantitative Assessment of Lid Margin Vascularity Using SS-OCTA

Not yet recruiting
  • Ss-octa
  • +2 more
    • (no location specified)
    Oct 15, 2023

    Relapsed Acute Myeloid Leukemia Trial in Saint Louis (Flotetuzumab, Donor lymphocyte infusion)

    Recruiting
    • Relapsed Acute Myeloid Leukemia
    • Saint Louis, Missouri
      Washington University School of Medicine
    Sep 7, 2022

    MGD-Meibomian Gland Dysfunction Trial in Wuhan, Hangzhou (Intense pulsed light, 0.3% hyaluronic acid eye drops)

    Completed
    • MGD-Meibomian Gland Dysfunction
    • Intense pulsed light
    • 0.3% hyaluronic acid eye drops
    • Wuhan, Hubei, China
    • +2 more
    Sep 11, 2023

    Leukemia, Acute Myeloid, MDS, Classical Hodgkin Lymphoma Trial in United States (MGD024)

    Recruiting
    • Leukemia, Acute Myeloid
    • +7 more
    • Denver, Colorado
    • +4 more
    Aug 29, 2022

    Healthy Subjects Trial in Baltimore (MGD010, Placebo, Hepatitis A vaccine)

    Completed
    • Healthy Subjects
    • Baltimore, Maryland
      PAREXEL Baltimore Early Phase Clinical Unit
    Feb 4, 2022

    Head Neck Cancer, Squamous Cell Carcinoma of Head and Neck Trial (enoblituzumab, MGA012, MGD013)

    Withdrawn
    • Head and Neck Cancer
    • Squamous Cell Carcinoma of Head and Neck
    • enoblituzumab
    • +2 more
    • (no location specified)
    Feb 4, 2022

    Colorectal Cancer Metastatic Trial in United States (MGD007 + MGA012)

    Completed
    • Colorectal Cancer Metastatic
    • MGD007 + MGA012
    • New Haven, Connecticut
    • +5 more
    Feb 4, 2022

    Metastatic Cancer, Cervical Cancer Trial in Houston (MGD019)

    Not yet recruiting
    • Metastatic Cancer
    • Cervical Cancer
    • Houston, Texas
      M D Anderson Cancer Center
    Jul 22, 2022

    Unresectable, Recurrent or Metastatic Melanoma, Untreated Mucosal or Acral Lentiginous Melanoma Trial in China (MGD013)

    Terminated
    • Unresectable, Recurrent or Metastatic Melanoma
    • Untreated Mucosal or Acral Lentiginous Melanoma
    • Beijing, Beijing, China
    • +12 more
    Apr 12, 2022

    Colorectal Carcinoma Trial in United States (MGD007)

    Completed
    • Colorectal Carcinoma
    • New Haven, Connecticut
    • +7 more
    Feb 4, 2022

    Acute Myeloid Leukemia, AML, AML, Adult Recurrent Trial (flotetuzumab)

    No longer available
    • Acute Myeloid Leukemia
    • +2 more
    • flotetuzumab
    • (no location specified)
    May 24, 2022

    Advanced Solid Tumor, Castration-Resistant Prostatic Cancer, Malignant Melanoma Trial in United States (MGC018, lorigerlimab)

    Recruiting
    • Advanced Solid Tumor
    • +6 more
    • vobramitamab duocarmazine
    • lorigerlimab
    • Los Angeles, California
    • +7 more
    Jan 10, 2023

    Meibomian Gland Dysfunction, Blepharitis, Demodex Infestation Trial (TP-03, TP-03 Vehicle)

    Not yet recruiting
    • Meibomian Gland Dysfunction
    • +2 more
    • (no location specified)
    Jul 13, 2022

    Androgen-Independent Prostatic Cancer, Androgen-Independent Prostatic Tumors, Prostate Cancer Recurrent Trial (lorigerlimab,

    Not yet recruiting
    • Androgen-Independent Prostatic Cancer
    • +8 more
    • lorigerlimab
    • +2 more
    • (no location specified)
    May 4, 2023

    Recurrent Acute Leukemia, Recurrent B Acute Lymphoblastic Leukemia, Recurrent Blastic Plasmacytoid Dendritic Cell Tumor Trial in

    Recruiting
    • Recurrent Acute Leukemia
    • +16 more
    • Duarte, California
      City of Hope Medical Center
    Nov 22, 2022

    Meibomian Gland Dysfunction Trial in Kowloon, Shatin (device, behavioral, drug)

    Recruiting
    • Meibomian Gland Dysfunction
    • Vectored thermal pulsation (VTP) therapy
    • +3 more
    • Kowloon, Hong Kong
    • +3 more
    Nov 26, 2022